Cullin 3 regulates ADAMs-mediated ectodomain shedding of amphiregulin

Biochem Biophys Res Commun. 2018 Apr 30;499(1):17-23. doi: 10.1016/j.bbrc.2018.03.097. Epub 2018 Mar 21.

Abstract

A disintegrin and metalloproteinase (ADAM) family are crucial enzymes for ectodomain shedding of multiple substrates and are involved in diverse biologic and pathologic processes. However, the molecular mechanism underlying substrate selectivity of ADAMs is poorly understood. In this study, we observed that disruption of actin polymerization by pharmacological inhibitors, latrunculin A (LatA) and cytochalasin D (CyD), induced ectodomain shedding of epidermal growth factor (EGF) family ligands. Induced shedding activity by LatA or CyD was suppressed by a metalloprotease inhibitor KB-R7785, indicating that ADAMs-mediated shedding is tightly controlled by actin cytoskeleton. We also investigated roles of cullin family, a component of cullin-RING based E3 ubiquitin ligases, in ectodomain shedding, since cullin family is implicated in the regulation of cytoskeletal dynamics. Knockdown of cullin 3 (Cul3) by a specific siRNA inhibited ectodomain shedding of amphiregulin (AREG), a member of EGF family, and responses were associated with activation of RhoA GTPase and induction of stress fiber formation. On the other hand, the RhoA inhibitor C3 transferase rescued AREG shedding reduced by Cul3 knockdown. These results describe a novel molecular mechanism of Cul3 to regulate AREG shedding by modulating cytoskeletal dynamics in a RhoA dependent manner.

Keywords: Actin; Amphiregulin; Cullin 3; Ectodomain shedding; RhoA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAM17 Protein / antagonists & inhibitors
  • ADAM17 Protein / genetics*
  • ADAM17 Protein / metabolism
  • ADP Ribose Transferases / pharmacology
  • Actin Cytoskeleton / drug effects
  • Actin Cytoskeleton / metabolism*
  • Actin Cytoskeleton / ultrastructure
  • Amphiregulin / genetics*
  • Amphiregulin / metabolism
  • Animals
  • Botulinum Toxins / pharmacology
  • Bridged Bicyclo Compounds, Heterocyclic / antagonists & inhibitors
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Cell Line, Tumor
  • Cullin Proteins / antagonists & inhibitors
  • Cullin Proteins / genetics*
  • Cullin Proteins / metabolism
  • Cytochalasin D / antagonists & inhibitors
  • Cytochalasin D / pharmacology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Gene Expression Regulation
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • Humans
  • Hydroxamic Acids / pharmacology
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / genetics
  • Isoenzymes / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Signal Transduction
  • Tetradecanoylphorbol Acetate / analogs & derivatives
  • Tetradecanoylphorbol Acetate / pharmacology
  • Thiazolidines / antagonists & inhibitors
  • Thiazolidines / pharmacology
  • rhoA GTP-Binding Protein / antagonists & inhibitors
  • rhoA GTP-Binding Protein / genetics
  • rhoA GTP-Binding Protein / metabolism

Substances

  • 12-O-tetradecanoylphorbol-1,3-acetate
  • AREG protein, human
  • Amphiregulin
  • Bridged Bicyclo Compounds, Heterocyclic
  • CUL3 protein, human
  • Cullin Proteins
  • Hydroxamic Acids
  • Isoenzymes
  • KB R7785
  • RNA, Small Interfering
  • Thiazolidines
  • RHOA protein, human
  • Cytochalasin D
  • ADP Ribose Transferases
  • exoenzyme C3, Clostridium botulinum
  • Botulinum Toxins
  • ADAM17 Protein
  • ADAM17 protein, human
  • rhoA GTP-Binding Protein
  • Tetradecanoylphorbol Acetate
  • latrunculin A
  • Glycine